Literature DB >> 403723

Endocrine morbidity in adults treated with cerebral irradiation for brain tumours during childhood.

S M Shalet, C G Beardwell, I A MacFarlane, P H Jones, D Pearson.   

Abstract

Hypothalamic-pituitary function was assessed in 20 adult subjects who were treated with cerebral irradiation for brain tumours during childhood between 8 and 32 years earlier. Nine patients showed impaired growth hormone (GH) responses to hypoglycaemia, of whom, 7 are below the third centile for standing height. All GH deficient subjects received more than 2950 rads to the hypothalamic-pituitary axis with a maximum dose of approximately 5000 rads being used in one case. Three subjects have an elevated basal serum thyroid stimulating hormone (TSH) level and 2 of these show an exaggerated TSH response to thyrotrophin releasing hormone (TRH) but no patient was clinically or biochemically hypothyroid. The rest of hypothalamic-pituitary function was essentially normal. This study shows that multiple pituitary hormone deficiencies do no develop with time when the radiation dose is below a critical level. Thus it appears that there is a gradation of radiation damage to the hypothalamic-pituitary axis which is dependent primarily on the dose received rather than the time interval after radiotherapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403723     DOI: 10.1530/acta.0.0840673

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  13 in total

Review 1.  Endocrine dysfunctions in patients treated for brain tumors: incidence and guidelines for management.

Authors:  A A Brandes; L M Pasetto; F Lumachi; S Monfardini
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

Review 2.  Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis.

Authors:  Natasha M Appelman-Dijkstra; Nieke E Kokshoorn; Olaf M Dekkers; Karen J Neelis; Nienke R Biermasz; Johannes A Romijn; Johannes W A Smit; Alberto M Pereira
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

Review 3.  Endocrine consequences of treatment of malignant disease in childhood: a review.

Authors:  S M Shalet; C G Beardwell
Journal:  J R Soc Med       Date:  1979-01       Impact factor: 5.344

4.  Growth hormone and segmental growth in survivors of head and neck embryonal rhabdomyosarcoma.

Authors:  J R Katz; P Bareille; G Levitt; R Stanhope
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

5.  Effect of treatment of malignant disease on growth in children.

Authors:  N K Griffin; J Wadsworth
Journal:  Arch Dis Child       Date:  1980-08       Impact factor: 3.791

Review 6.  Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications.

Authors:  Monika L Metzger; Lillian R Meacham; Briana Patterson; Jacqueline S Casillas; Louis S Constine; Nobuko Hijiya; Lisa B Kenney; Marcia Leonard; Barbara A Lockart; Wendy Likes; Daniel M Green
Journal:  J Clin Oncol       Date:  2013-02-04       Impact factor: 44.544

7.  Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours.

Authors:  E A Livesey; C G Brook
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

8.  Growth response to growth hormone therapy following cranial irradiation.

Authors:  P E Clayton; S M Shalet; D A Price
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

9.  Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study.

Authors:  Daniel M Green; Toana Kawashima; Marilyn Stovall; Wendy Leisenring; Charles A Sklar; Ann C Mertens; Sarah S Donaldson; Julianne Byrne; Leslie L Robison
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

10.  Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy.

Authors:  P S Sharp; T J Fallon; O J Brazier; L Sandler; G F Joplin; E M Kohner
Journal:  Diabetologia       Date:  1987-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.